1. Ager IR, Barnes AC, Danswan GW, Hairsine PW, Kay DP, Kennewell PD, Matharu SS, Miller P, Robson P, Rowlands DA, Tully WR, Westwood R (1988) Synthesis and oral antiallergic activity of carboxylic acids derived from imidazo[2,1-c][1,4]benzoxazines, imidazo[1,2-a]quinolines, imidazo[1,2-a]quinoxalines, imidazo[1,2-a]quinoxalinones, pyrrolo[1,2-a]quinoxalinones, pyrrolo[2,3-a]quinoxalinones, and imidazo[2,1-b]benzothiazoles. J Med Chem 31:1098–1115
2. Chua M, Shi D, Wrigley S, Bradshaw TD, Hutchinson I, Shaw PN, Barrett DA, Stanley LA, Stevens MFG (1999) Antitumour benzothiazoles. 7. Synthesis of 2-(4-acylaminophenyl)benzothiazoles and investigations into the role of acetylation in the antitumour activities of the parent amines. J Med Chem 42:381–392
3. Clinical and Laboratory Standards Institute (CLSI) (formerly NCCLS) (2006a) Performance standards for antimicrobial disk susceptibility tests, approved standard, M2-A9, Clinical and Laboratory Standards Institute, 940 West Valley Road, Wayne, PA
4. Clinical and Laboratory Standards Institute (CLSI) (formerly NCCLS) (2006b) Performance standards for antimicrobial susceptibility testing, 16th ınformational supplement. CLSI M100-S16, Clinical and Laboratory Standards Institute, 940 West Valley Road, Wayne, PA
5. Clinical and Laboratory Standards Institute (CLSI) (formerly NCCLS) (2006c) Reference method for broth dilution antifungal susceptibility testing yeast, approved standard, M27-A3, Clinical and Laboratory Standards Institute, 940 West Valley Road, Wayne, PA